PJMHS 2021
DOI: 10.53350/pjmhs2115123322
|View full text |Cite
|
Sign up to set email alerts
|

Depression and Anxiety among patients suffering from mild to moderate Covid-19 Disease

Abstract: Aim: To look for the presence of depression and anxiety among patients suffering from mild to moderate COVID-19 disease. Methodology: This cross sectional study was conducted at Department of Medicine, Pakistan Ordinance Factory (POF) Hospital Wah Cantt from 1st April 2020 to 30th September 2020. Patients presenting to Pakistan Ordinance Factory (POF) Hospital Wah Cantt with relevant symptoms and tested positive on polymerase chain reaction for COVID-19 were included in the study. Hospital anxiety and depressi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 19 publications
0
1
0
Order By: Relevance
“…Additionally, healthcare professionals working in COVID-19 hospitals have been found to experience unusually high levels of depression [63], and a substantial proportion of hospitalized patients with COVID-19 exhibit symptoms of depression, with a reported prevalence of 75% [64]. Depression is also commonly observed in patients with mild to moderate COVID-19 disease [65], and symptoms of anxiety and depression frequently manifest themselves as psychological responses to the pandemic, potentially linked to disturbed sleep [66]. A meta-analysis indicates a depression prevalence of 27.60% [67], and a systematic review demonstrates higher depression scores in the general population compared to pre-COVID-19 levels [68].…”
Section: Depressionmentioning
confidence: 99%
“…Additionally, healthcare professionals working in COVID-19 hospitals have been found to experience unusually high levels of depression [63], and a substantial proportion of hospitalized patients with COVID-19 exhibit symptoms of depression, with a reported prevalence of 75% [64]. Depression is also commonly observed in patients with mild to moderate COVID-19 disease [65], and symptoms of anxiety and depression frequently manifest themselves as psychological responses to the pandemic, potentially linked to disturbed sleep [66]. A meta-analysis indicates a depression prevalence of 27.60% [67], and a systematic review demonstrates higher depression scores in the general population compared to pre-COVID-19 levels [68].…”
Section: Depressionmentioning
confidence: 99%